-
Genomic landscape of malignant peripheral nerve sheath tumor (MPNST)
Study
EGAS00001006069
-
Molecular and functional profiling of plasmablastic lymphoma
Study
EGAS00001004659
-
Tumour gene expression signature in primary melanoma predicts long-term outcomes: A prospective multicentre study
Study
EGAS00001004664
-
Clear cell sarcoma sequencing data
Study
EGAS00001006072
-
Genomic and transcriptomic analysis of baseline PDAC patients' tumors from the OXIRI phase 1b clinical trial
Study
EGAS00001006073
-
STAT5 is a therapeutically targetable vulnerability in cutaneous T-cell lymphoma
Study
EGAS00001004719
-
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
Study
EGAS00001005592
-
Osteosarcoma sequencing data
Study
EGAS00001005600
-
Regulatory T cell transcriptomic reprogramming characterizes adverse events by checkpoint inhibitors in solid tumors
Study
EGAS00001004694
-
Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma
Study
EGAS00001005617